Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125848051 | 12584805 | 1 | I | 20160627 | 20160716 | 20160722 | 20160722 | EXP | US-ASTRAZENECA-2016SE78676 | ASTRAZENECA | 66.00 | YR | M | Y | 79.40000 | KG | 20160722 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125848051 | 12584805 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | HF0173 | 0 | TABLET | ||||||||
| 125848051 | 12584805 | 2 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | HF0173 | 0 | TABLET | ||||||||
| 125848051 | 12584805 | 3 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | 0 | 40 | MG | CAPSULE | QD | ||||||
| 125848051 | 12584805 | 4 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | 0 | 40 | MG | CAPSULE | QD | ||||||
| 125848051 | 12584805 | 5 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | 20.6 | MG | BID | ||||||||
| 125848051 | 12584805 | 6 | C | TUMS | CALCIUM CARBONATE | 1 | Oral | FOR OVER 40 YEARS-TAKES 2 BY MOUTH AS NEEDED | 0 | ||||||||||
| 125848051 | 12584805 | 7 | C | ROLAIDS | CALCIUM CARBONATEMAGNESIUM HYDROXIDE | 1 | Oral | FOR OVER 40 YEARS-TAKES 2 BY MOUTH AS NEEDED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125848051 | 12584805 | 1 | Gastrooesophageal reflux disease |
| 125848051 | 12584805 | 2 | Peptic ulcer |
| 125848051 | 12584805 | 3 | Gastrooesophageal reflux disease |
| 125848051 | 12584805 | 4 | Peptic ulcer |
| 125848051 | 12584805 | 6 | Dyspepsia |
| 125848051 | 12584805 | 7 | Dyspepsia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125848051 | 12584805 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125848051 | 12584805 | Abdominal distension | |
| 125848051 | 12584805 | Chronic obstructive pulmonary disease | |
| 125848051 | 12584805 | Drug resistance | |
| 125848051 | 12584805 | Dyspepsia | |
| 125848051 | 12584805 | Nausea | |
| 125848051 | 12584805 | Pneumothorax | |
| 125848051 | 12584805 | Respiratory tract irritation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125848051 | 12584805 | 1 | 2011 | 0 | ||
| 125848051 | 12584805 | 2 | 2011 | 0 | ||
| 125848051 | 12584805 | 3 | 2011 | 0 | ||
| 125848051 | 12584805 | 4 | 2011 | 0 | ||
| 125848051 | 12584805 | 5 | 20160716 | 0 |